CXCR4 3'UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity

European Journal of Cell Biology

Volumn 94, Issue 10, 2015, Pages 458-469

  Zheng, Tianjing ^a   Chou, Jinjiang ^a   Zhang, Feng ^a   Liu, Yu ^a   Ni, Haiwei ^b   Li, Xiaoman ^a   Zheng, Lufeng ^a   Tang, Tingting ^a   Jin, Liang ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Competitive endogenous RNA; CXCR4 3'UTR; EGFR; MiR 146a; TRAF6

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 146A; ONCOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNTRANSLATED RNA; 3' UNTRANSLATED REGION; CXCR4 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; MICRORNA; MIRN146 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; METASTASIS; ONCOGENE; PRIORITY JOURNAL; TUMOR GROWTH; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR INVASION;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HUMANS; MCF-7 CELLS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CXCR4; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84946486481     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2015.05.010     Document Type: Article

References (50)

1. Ablett M.P., O'Brien C.S., Sims A.H., Farnie G., Clarke R.B. A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity. Oncotarget 2014, 5:599-612.
2. Al-Souhibani N., Al-Ghamdi M., Al-Ahmadi W., Khabar K.S. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. Carcinogenesis 2014, 35:1983-1992.
3. Ala U., Karreth F.A., Bosia C., Pagnani A., Taulli R., Leopold V., Tay Y., Provero P., Zecchina R., Pandolfi P.P. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7154-7159.
4. Ali S., Ahmad A., Aboukameel A., Ahmed A., Bao B., Banerjee S., Philip P.A., Sarkar F.H. Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling. Cancer Lett. 2014, 351:134-142.
5. Alsayed Y., Ngo H., Runnels J., Leleu X., Singha U.K., Pitsillides C.M., Spencer J.A., Kimlinger T., Ghobrial J.M., Jia X., Lu G., Timm M., Kumar A., Cote D., Veilleux I., Hedin K.E., Roodman G.D., Witzig T.E., Kung A.L., Hideshima T., Anderson K.C., Lin C.P., Ghobrial I.M. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007, 109:2708-2717.
6. Aravindan B.K., Prabhakar J., Somanathan T., Subhadra L. The role of chemokine receptor 4 and its ligand stromal cell derived factor 1 in breast cancer. Ann. Transl. Med. 2015, 3:23.
7. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
8. Boudot A., Kerdivel G., Lecomte S., Flouriot G., Desille M., Godey F., Leveque J., Tas P., Le Drean Y., Pakdel F. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration. BMC Cancer 2014, 14:407.
9. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
10. Cojoc M., Peitzsch C., Trautmann F., Polishchuk L., Telegeev G.D., Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. OncoTargets Ther. 2013, 6:1347-1361.
11. Creekmore A.L., Silkworth W.T., Cimini D., Jensen R.V., Roberts P.C., Schmelz E.M. Changes in gene expression and cellular architecture in an ovarian cancer progression model. PLoS ONE 2011, 6:e17676.
12. Doig T.N., Hume D.A., Theocharidis T., Goodlad J.R., Gregory C.D., Freeman T.C. Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics 2013, 14:469.
13. Dubrovska A., Elliott J., Salamone R.J., Telegeev G.D., Stakhovsky A.E., Schepotin I.B., Yan F., Wang Y., Bouchez L.C., Kularatne S.A., Watson J., Trussell C., Reddy V.A., Cho C.Y., Schultz P.G. CXCR4 expression in prostate cancer progenitor cells. PLoS ONE 2012, 7:e31226.
14. Figliuzzi M., Marinari E., De Martino A. MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys. J. 2013, 104:1203-1213.
15. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007, 1:313-323.
16. Huang L., Verstrepen L., Heyninck K., Wullaert A., Revets H., De Baetselier P., Beyaert R. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells. Oncogene 2008, 27:6131-6140.
17. Hung P.S., Liu C.J., Chou C.S., Kao S.Y., Yang C.C., Chang K.W., Chiu T.H., Lin S.C. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLOS ONE 2013, 8:e79926.
18. Hurst D.R., Edmonds M.D., Scott G.K., Benz C.C., Vaidya K.S., Welch D.R. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69:1279-1283.
19. Jiang W., Kong L., Ni Q., Lu Y., Ding W., Liu G., Pu L., Tang W., Kong L. miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6. PLOS ONE 2014, 9:e101530.
20. Ju L., Zhou C. Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer. Cancer Biomarks 2013, 13:329-336.
21. Kato H., Liao Z., Mitsios J.V., Wang H.Y., Deryugina E.I., Varner J.A., Quigley J.P., Shattil S.J. The primacy of beta1 integrin activation in the metastatic cascade. PLoS ONE 2012, 7:e46576.
22. Kumar M.S., Armenteros-Monterroso E., East P., Chakravorty P., Matthews N., Winslow M.M., Downward J. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 2014, 505:212-217.
23. Kumaraswamy E., Wendt K.L., Augustine L.A., Stecklein S.R., Sibala E.C., Li D., Gunewardena S., Jensen R.A. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene 2014, (in press). 10.1038/onc.2014.363.
24. Labbaye C., Spinello I., Quaranta M.T., Pelosi E., Pasquini L., Petrucci E., Biffoni M., Nuzzolo E.R., Billi M., Foa R., Brunetti E., Grignani F., Testa U., Peschle C. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat. Cell Biol. 2008, 10:788-801.
25. Li Y., Vandenboom T.G., Wang Z., Kong D., Ali S., Philip P.A., Sarkar F.H. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010, 70:1486-1495.
26. Liu K., Guo L., Guo Y., Zhou B., Li T., Yang H., Yin R., Xi T. AEG-1 3'-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity. Eur. J. Cell Biol. 2015, 94:22-31.
27. Liu R., Liu C., Chen D., Yang W.H., Liu X., Liu C.G., Dugas C.M., Tang F., Zheng P., Liu Y., Wang L. FOXP3 controls an miR-146/NFkappaB negative feedback loop that inhibits apoptosis in breast cancer cells. Cancer Res. 2015, 75:1703-1713.
28. Oon M.L., Thike A.A., Tan S.Y., Tan P.H. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res. Treat. 2015, 150:31-41.
29. Poliseno L., Pandolfi P.P. PTEN ceRNA networks in human cancer. Methods 2015, 77-78:41-50.
30. Punj V., Matta H., Schamus S., Tamewitz A., Anyang B., Chaudhary P.M. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 2010, 29:1835-1844.
31. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358.
32. Sarvaiya P.J., Guo D., Ulasov I., Gabikian P., Lesniak M.S. Chemokines in tumor progression and metastasis. Oncotarget 2013, 4:2171-2185.
33. Satelli A., Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol. Life Sci. 2011, 68:3033-3046.
34. Spinello I., Quaranta M.T., Riccioni R., Riti V., Pasquini L., Boe A., Pelosi E., Vitale A., Foa R., Testa U., Labbaye C. MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Blood Cancer J. 2011, 1:e26.
35. Sumazin P., Yang X., Chiu H.S., Chung W.J., Iyer A., Llobet-Navas D., Rajbhandari P., Bansal M., Guarnieri P., Silva J., Califano A. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011, 147:370-381.
36. Sun X., Charbonneau C., Wei L., Yang W., Chen Q., Terek R.M. CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. Mol. Cancer Ther. 2013, 12:1163-1170.
37. Sun Y., Mao X., Fan C., Liu C., Guo A., Guan S., Jin Q., Li B., Yao F., Jin F. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis. Tumour Biol. 2014, 35:7765-7773.
38. Tang F., Zhang R., He Y., Zou M., Guo L., Xi T. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS ONE 2012, 7:e35435.
39. Tay Y., Kats L., Salmena L., Weiss D., Tan S.M., Ala U., Karreth F., Poliseno L., Provero P., Di Cunto F., Lieberman J., Rigoutsos I., Pandolfi P.P. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357.
40. Tay Y., Rinn J., Pandolfi P.P. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014, 505:344-352.
41. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
42. Ventura A., Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591.
43. Vimalraj S., Miranda P.J., Ramyakrishna B., Selvamurugan N. Regulation of breast cancer and bone metastasis by microRNAs. Dis. Markers 2013, 35:369-387.
44. Wang D., Liu D., Gao J., Liu M., Liu S., Jiang M., Liu Y., Zheng D. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration. FEBS J. 2013, 280:3340-3353.
45. Weitzenfeld P., Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 2014, 352:36-53.
46. Wurth R., Bajetto A., Harrison J.K., Barbieri F., Florio T. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front. Cell Neurosci. 2014, 8:144.
47. Yang J., Li T., Gao C., Lv X., Liu K., Song H., Xing Y., Xi T. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett. 2014, 588:3218-3224.
48. Yang P., Guo L., Duan Z.J., Tepper C.G., Xue L., Chen X., Kung H.J., Gao A.C., Zou J.X., Chen H.W. Histone methyltransferase NSD2/MMSET mediates constitutive NF-kappaB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol. Cell Biol. 2012, 32:3121-3131.
49. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.
50. Zlotnik A., Yoshie O. The chemokine superfamily revisited. Immunity 2012, 36:705-716.